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The reduced nicotinamide adenine dinucleo-
tide phosphate (NADPH) oxidase of neutro-
phils and macrophages plays an essential role in 
the mechanisms by which these cells destroy en-
gulfed pathogens (1, 2). The delivery of super-
oxide anion (O2
−) by this enzyme complex into 
the phagosome is thought to indirectly activate 
several classes of protease (3), and O2
− itself can 
be directly converted into a variety of destruc-
tive molecular species (reactive oxygen species 
[ROS] and halide derivatives) (4, 5). Together 
with the delivery of other nonoxidant-depen-
dent microbicidal agents into the phagosome, 
e.g., defensins (6), the NADPH oxidase plays a 
central role in our defense mechanisms against 
invading microbes.
Although the role of the phagocyte NADPH 
oxidase in microbe killing is clear, it has be-
come apparent that the same, or closely homol-
ogous, enzyme complexes also exist in many 
other cell types, e.g., in lymphocytes and endo-
thelia (1, 5, 7). The role of ROS produced by 
the NADPH oxidases in these other cell types is 
still largely undefi  ned but is likely to include 
intra- and peri-cellular signaling via H2O2-
  mediated oxidation of critical cysteine residues 
in target proteins. Thus far, these target proteins 
are largely thought to be members of the pro-
tein tyrosine phosphate phosphatase super  family 
that are intermediaries in cell surface receptor–
regulated signaling pathways (8).
The core molecular components of the 
phagocyte NADPH oxidase are a b-type mem-
brane-bound cytochrome consisting of gp91phox 
and p22phox subunits (cytochrome b558) and four 
soluble components: rac-2, p67phox, p47phox, and 
p40phox (1, 2). On activation, the soluble com-
ponents form an active complex with the b-type 
cytochrome and electrons are transferred from 
NADPH, across the membrane, and are deliv-
ered to molecular oxygen to generate the su-
peroxide anion, O2
−. The importance of the 
NADPH oxidase is clearly witnessed by mole-
cular defects in components of the NADPH 
  oxidase, which lead to chronic granulomatous 
disease (CGD), a genetic disorder in which 
  patients suff   er recurrent fungal and bacterial 
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The generation of reactive oxygen species (ROS) by the reduced nicotinamide adenine 
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an essential component in bacterial killing.
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  infections (9, 10). Additionally, a phagocyte immunodefi  -
ciency has also been described in a patient with dysfunctional 
rac-2 (11). The molecular events that underlie NADPH oxi-
dase activation are still incompletely understood, but there 
is now overwhelming evidence that key aspects are GTP-
rac-2 binding to p67phox and multiple phosphorylation of 
p47phox (1, 2, 12), which promote complex formation with 
each other and the cytochrome to form a catalytically com-
petent enzyme.
There is a very large range of stimuli that activate the ox-
idase in cells such as neutrophils and macrophages, and hence 
there is a large variety of receptor subtypes and associated sig-
naling pathways that underlie this capability. Microbes are 
phagocytosed via a series of overlapping and redundant re-
ceptors, such as members of the integrin and antibody recep-
tor families, depending on the organisms themselves and the 
type and degree of opsonization (13, 14), resulting in subse-
quent activation of NADPH oxidase on both the plasma and 
phagosomal membranes. Cells such as neutrophils also un-
dergo rapid activation of their NADPH oxidase in response 
to soluble stimuli, such as formylated peptides (e.g., FMLP), 
leukotrienes (e.g., LTB4), and components of complement 
(C5a) (15). Furthermore, a variety of other infl  ammatory 
agents, which include cytokines such as TNF-α, GM-CSF, 
IL-8, and low doses of the primary stimuli themselves, col-
lectively “prime” the oxidase, resulting in substantial up-
  regulation of NADPH oxidase activity in response to primary 
stimuli at the site of infl  ammation (15–17). As a consequence, 
a very large number of intracellular signaling pathways 
have been shown to infl  uence NADPH oxidase activation. 
Progress has been made defi  ning some of these pathways, 
e.g., the coupling of receptor activation to guanine nucleo-
tide exchange on rac (18–21) and protein kinase C–mediated 
phosphorylation on p47phox (22–24 and previous references), 
but it is already clear that these sit within a web of yet 
more, ill-defi  ned regulatory inputs into the oxidase. For ex-
ample, it is known that several oxidase components are the 
targets of complex patterns of phosphorylation and phospho-
lipid   binding driven by mitogen-activated protein kinase 
(MAPK) and phosphoinositide 3-kinase (PI3K) signaling 
pathways (25–31).
Among the NADPH oxidase subunits, p40phox is perhaps 
the least well understood. It is known to bind p67phox via re-
ciprocal PB1 domain dimerization (32, 33), forming a tight 
complex in the cytosol of resting neutrophils (34, 35); how-
ever, there is some debate as to whether it is also found in 
a trimeric complex with p67phox and p47phox or whether this 
complex only occurs on activation or priming (22, 36, 37). 
p40phox is not required to reconstitute anionic detergent-
  stimulated oxidase activity in recombinant assays (34), and 
mutations in the p40phox gene have not been described in 
cases of CGD, leading to the view that it is not essential for 
NADPH oxidase activity. There are several reports, how-
ever, that suggest that, under some assay conditions, p40phox 
can infl  uence oxidase activity in vitro (37–40) and several 
confl  icting reports using cell-based assays that have suggested 
that p40phox is either a positive or negative regulator of the 
NADPH oxidase (41–43). p40phox has a clearly defi  ned do-
main structure (PX, PB1, and SH3 domains) that is evolu-
tionarily conserved and undergoes stimulated phosphorylation 
paralleling NADPH oxidase activation (44, 45). The PX do-
main has high specifi  city and affi   nity for binding the class III 
PI3K product PtdIns3P (37, 46, 47), but the physiological 
relevance of this interaction has yet to be shown in vivo. 
Similarly, the SH3 domain has been shown to bind a poly-
proline motif in p47phox with low affi   nity, but the true in vivo 
ligand for this domain has yet to be conclusively identifi  ed 
(36, 48, 49). Furthermore, although several binding partners 
for p40phox have been described, including moesin (50), coro-
nin (51), thioredoxin (52), and Ku70 (53), these have not im-
mediately provided a molecular explanation for the role of 
p40phox. To defi  ne the requirement for p40phox in NADPH 
oxidase regulation, we have created mice with a lesion in the 
p40phox gene and present the fi  rst characterization of NADPH 
oxidase activation and bacterial killing in neutrophils from 
p40phox−/− animals.
RESULTS
p40phox−/− mice are viable and produce 
differentiated neutrophils
p40phox−/− mice were produced by standard gene-targeting 
strategies (see Materials and methods and Fig. S1 A, which 
is available at http://www.jem.org/cgi/content/full/
jem.20052069/DC1). Two independent embryonic stem 
cell lines were used to derive two independent strains of 
p40phox−/− mice. These two strains could not be distinguished 
on the basis of any of the experiments presented, and, where 
appropriate, data is compiled from several animals of each 
strain. p40phox−/−, p40phox+/−, and p40phox+/+ animals were 
produced from the breeding of p40phox+/− heterozygotes in 
the expected Mendelian ratios and appeared healthy and fer-
tile when kept under barrier conditions. p40phox−/− mice had 
normal organ weights (Fig. S2, available at http://www.jem.
org/cgi/content/full/jem.20052069/DC1) and normal blood 
cell counts (Fig. 1 A).
We used a mouse monoclonal antibody to p40phox to inves-
tigate the tissue distribution of p40phox protein. Amongst the 
  tissues examined, we could only fi  nd strong evidence for 
  immuno-detectable protein that was absent in equivalent 
p40phox−/− samples (Fig. 1 B, arrowheads) in both bone mar-
row–derived neutrophils (BMNs) and in the spleen, suggesting 
that p40phox expression is highly restricted. We could not detect 
expression of p40phox in BMNs from p40phox−/− mice using 
three diff   erent monoclonal and polyclonal antibodies raised 
against p40phox (Fig. 1 C and unpublished data), indicating suc-
cessful targeting of the p40phox gene. Expression of p47phox was 
unaff  ected by the absence of p40phox, but expression of p67phox 
was signifi  cantly reduced (Fig. 1 C). Careful quantitation indi-
cated that p67phox levels in BMNs from p40phox−/− mice were 
reduced to 44.8 ± 4.3% of wild-type levels (Fig. 1 E). p40phox+/− 
BMNs demonstrated 71.9 ± 3.9% and 15.3 ± 4.0% reductions 
in p40phox and p67phox, respectively (Fig. 1, D and E).JEM VOL. 203, August 7, 2006  1929
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BMNs from p40phox−/− mice were able to support normal 
phagocytic uptake of Staphylococcus aureus (Fig. 2 A) and 
  zymosan (unpublished data), and normal activation of PKB, 
p38 MAPK, and p42/44 MAPK in response to FMLP 
(Fig. 2 B). These results suggest that the functions of several 
receptor classes characteristic of diff  erentiated neutrophils are 
intact in BMNs from p40phox−/− mice.
p40phox−/− neutrophils show substantially reduced oxidase 
activation in response to several soluble stimuli
We characterized production of ROS in response to FMLP 
in either unprimed, mTNF-α–, or mGM-CSF–primed 
BMNs isolated from p40phox−/−, p40phox+/−, and p40phox+/+ 
mice. ROS production was measured by a horseradish per-
oxidase (HRP)-dependent chemiluminescence assay that 
provides a rate measure of O2
− production into the extracel-
lular space. ROS production under each of these circum-
stances was severely reduced in the p40phox−/− mice ( 69–84% 
defective; Fig. 3, A–C). The kinetics of the remaining ROS 
production were similar in p40phox−/− neutrophils compared 
with the wild-type, and the dose-response curves to FMLP 
showed only a small shift to higher concentrations (Fig. 3, 
A–C). PMA is often used to bypass cell surface receptors and 
induce a more direct activation of the NADPH oxidase via, 
amongst less well-defi  ned pathways, a direct protein kinase C–
mediated phosphorylation of p47phox. PMA-induced produc-
tion of ROS in p40phox−/− neutrophils was also substantially 
reduced compared with the wild-type (Fig. 3 D) and showed 
negligible shifts in the dose-response curves.
p40phox−/− neutrophils show variable reductions in oxidase 
activation in response to different particulate stimuli
We characterized ROS responses in both primed and 
unprimed BMNs from p40phox−/− and p40pho+/+ mice in re-
sponse to various particulate stimuli. We initially measured 
ROS production using luminol-dependent luminescence in 
the absence of HRP, which previous work has indicated is 
a rate measure of ROS production in the vicinity of endoge-
nous peroxidases, largely thought to arise from the coincident 
deposition of ROS and myeloperoxidase into the phagosome 
(54). This is supported by our own data indicating little eff  ect 
of adding extracellular HRP in these assays (unpublished 
data). Under these circumstances, there were signifi  cant dif-
ferences in the relative reductions in ROS production seen 
with p40phox−/− neutrophils compared with the wild-type, 
depending on the nature of the stimulus (Fig. 4).
Priming the cells with mTNF-α and mGM-CSF caused 
a signifi  cant but relatively minor increase in the rate of ROS 
Figure 1.  Blood cell counts and phox protein expression in 
p40phox−/− mice. (A) Peripheral blood from p40phox+/+ and p40phox−/− 
animals was analyzed in a Vetabc animal blood cell counter. WBC, white 
blood cells; RBC, red blood cells; Plt, platelets, Lymph, lymphocytes; Mono, 
monocytes; Gran, granulocytes. Data represented are mean percentage of 
wild-type counts ± SE (n = 12). (B) 30 μg of clarifi  ed, homogenized 
tissues from p40phox+/+ and p40phox−/− animals was subjected to SDS-
PAGE and immunoblotted for p40phox. Arrowheads indicate position of 
p40phox. We routinely observed immunoreactive bands in the spleen and 
thymus from p40phox−/− animals. We do not know whether they are prod-
ucts of alternative splicing of p40phox gene transcripts. (C) BMNs from 
p40phox+/+, p40phox+/−, and p40phox−/− animals were sonicated into SDS 
sample buffer, subjected to SDS-PAGE, and immunoblotted for p40phox, 
p47phox, and p67phox. Graphs represent quantitation of p40phox (D) and 
p67phox (E) levels in BMNs as mean percentage of wild-type samples ± SE 
(n = 10–13) from 6–10 independent experiments using three to six mice 
per preparation.
Figure 2.  p40phox−/− neutrophils exhibit normal S. aureus 
phagocytosis and FMLP-induced signal transduction. (A) Primed 
p40phox+/+ and p40phox−/− BMNs were adhered to glass and allowed to 
phagocytose serum-opsonized, FITC-labeled S. aureus for 40 min. Coverslips 
were washed and fi  xed, and the mean number of internalized bacteria per 
  neutrophil was determined. 300 neutrophils were examined (n = 2). 
(B) p40phox+/+ and p40phox−/− BMNs were incubated for 1min in the pres-
ence (+) or absence (−) of 10 μM FMLP. Resultant lysates were split be-
tween two blots and probed with phospho- (P) and total (T) antibodies 
against PKB, p38 MAPK, and p42/44 Erk. Graphs represent quantifi  cation of 
phospho-protein levels ± the range from a single experiment representative 
of three experiments. Black bars, +/+; white bars, −/−. Units are arbitrary.1930  P40PHOX IS REQUIRED FOR BACTERIAL KILLING | Ellson et al.
generation in response to both unopsonized and opsonized 
zymosan and S. aureus, and a major increase in both the 
rate and magnitude of ROS generation in response to IgG 
latex beads. Looking across the full range of the responses to 
the various stimuli, the defi  ciencies in ROS production in 
the p40phox−/− versus p40phox+/+ neutrophils were similar be-
tween the primed and unprimed cells (Fig. 4 A and unpub-
lished data), suggesting that the p40phox defi  ciency  was 
not correlated with a specifi  c defi  ciency in this type of 
  priming mechanism.
Opsonization of zymosan with IgG or serum increased 
slightly the rate of ROS generation relative to the unopso-
nized particles but made relatively little diff  erence to the level 
of the defect in the p40phox−/− versus p40phox+/+ neutrophils 
(Fig. 4 and not depicted). Serum opsonization of S. aureus in-
creased signifi  cantly the rate and magnitude of ROS produc-
tion in response to these stimuli but again made relatively 
little diff  erence to the level of defect in the p40phox−/− neu-
trophils (Fig. 4). The ROS responses to S. aureus, however, 
were much more aff  ected by the loss of p40phox than the re-
sponses to zymosan. The amounts of ROS produced by these 
stimuli over 2 h, across several experiments, are presented in 
Fig. 4 B ( 84 vs. 30% defective for S. aureus and zymosan, 
respectively). These diff   erences remained when varying 
amounts of these two stimuli were used (unpublished data), 
indicating a fundamental diff  erence in their relative sensitiv-
ity to the loss of p40phox. Zymosan and S. aureus, even in their 
unopsonized states, represent complex stimuli with respect to 
the receptors they engage; thus, this diff  erence cannot at this 
stage be ascribed to particular receptor-associated signaling 
mechanisms. In an attempt to provide a phagocytic stimulus 
with a defi  ned mechanism of entry, we made use of latex 
beads coated with IgG. Under the conditions of our assays, 
the ROS response to these beads was highly dependent on 
the IgG coating (Fig. 4); thus, it is reasonable to assume that 
an Fc receptor of some type plays a central role in the ROS 
response to this stimulus. p40phox−/− neutrophils exhibited a 
very severe defect in ROS production to IgG latex beads 
( 85%; Fig. 4), indicating that the signaling pathways from 
Fc receptors to the oxidase are highly dependent on p40phox.
Given the requirement for both ROS and peroxidase 
  activity in the luminol-dependent chemiluminescence assay, 
and the potential ambiguity in interpretation of a defi  ciency 
that this measurement provides, we also sought to measure 
NADPH oxidase activity in p40phox−/− and p40phox+/+ neu-
trophils by measuring the rate of O2 consumption. It has 
been shown previously that NADPH   oxidase–catalyzed 
  consumption of O2 during a stimulated “respiratory burst” 
dominates O2 consumption by other routes, e.g., mitochon-
drial respiration (55), and hence provides a measure of sub-
strate use that should be independent of the location of the 
oxidase or the pathways of ROS use. PMA-, IgG-Zym–, 
and  S. aureus–stimulated O2 consumption showed similar 
  relative diff  erences between p40phox+/+ and p40phox−/− BMNs 
as those previously described by the chemiluminescence 
measurements (Fig. 5, A and B). Thus, the p40phox−/− 
  neutrophils showed large defi   ciencies in O2 consumption 
when challenged with PMA and S. aureus yet a relatively 
  minor   defi   ciency when challenged with zymosan, despite 
similar absolute rates of O2 consumption for each sti-
mulus (Fig. 5 A).
To confi  rm that ROS accumulation by p40phox−/− BMNs 
in response to IgG-Zym was directed into the phagosome, 
we took advantage of the fact that O2
−-catalyzed reduction 
of soluble formazan salts to form insoluble, colored products 
can be used as a semiquantitative assay for the location of 
NADPH oxidase activity. Substantial formation of dark pur-
ple nitroblue tetrazolium (NBT) deposits could be seen in 
Figure 3.  p40phox−/− neutrophils have severe defects in ROS pro-
duction in response to soluble stimuli. BMNs from p40phox+/+, 
p40phox+/−, and p40phox−/− animals were analyzed for soluble stimulus-
induced ROS production using HRP-dependent, luminol-dependent chemi-
luminescence. Duplicate wells of BMNs (3.75 × 105/well) were stimulated 
in a luminometer and ROS production (measured in relative light units per 
second, rlu/sec) was followed over time. 10 μM of unprimed FMLP (A), 10 μM 
mTNF-α–primed FMLP (B), 10 μM mGM-CSF–primed FMLP (C), and 
300 nM PMA (D). Response kinetics (top line graph), total integrated re-
sponses as percentage of wild-type (bar graph), and agonist dose-response 
curves (bottom graph) are shown. Dose-response curves are standardized 
to 100% with 300 nM PMA and 30 μM FMLP, respectively. Black, +/+; 
gray, +/−; white, −/−. All data are means ± SE (n = 6) from three inde-
pendent experiments using three to six mice per preparation.JEM VOL. 203, August 7, 2006  1931
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zymosan-containing phagosomes in both p40phox+/+ and 
p40phox−/− neutrophils (Fig. 5 C), suggesting that substantial 
oxidase activity must be present in these structures.
p40phox−/− neutrophils adherent on fi  brinogen cannot 
generate ROS in response to TNF-𝗂
Neutrophils attached to a variety of surfaces via their cell sur-
face integrins can generate substantial quantities of extracellu-
lar ROS in response to costimulation by cytokines (e.g., TNF-α), 
chemoattractants (e.g., FMLP), or Fc receptors (FcγRIII in 
murine neutrophils) (56–58). We investigated the ability of 
BMNs from p40phox−/− mice attached to a fi  brinogen surface 
to produce ROS in response to mTNF-α, a response previ-
ously established to be dependent on β2 integrin engagement 
(59, 60). p40phox−/− neutrophils exhibited a remarkable defi  -
ciency in this response compared with their wild-type con-
trols (96.7 ± 0.7% reduced; Fig. 6, A and C). Similar defects 
were seen upon costimulation with FMLP and mGM-CSF 
(unpublished data). p40phox−/− neutrophils also exhibited a 
  severe defi  ciency in activation of their oxidase in response to 
direct cross-linking of their β2 integrins by an anti-β2 anti-
body (95.1 ± 2.7% reduced; Fig. 6, B and C), a response that 
recent work has suggested is probably mediated via coopera-
tion between β2 integrin and FcγRIII activation (58). 
p40phox−/− neutrophils expressed normal levels of cell surface 
β2 integrins and demonstrated no defect in TNF-α–induced 
adhesion and spreading on fi   brinogen (Fig. 6, D and E). 
Figure 4.  p40phox−/− neutrophils have differing defects in ROS 
production in response to particulate stimuli. BMNs from p40phox+/+ 
and p40phox−/− animals were analyzed for particulate stimulus-induced 
ROS production using luminol-dependent chemiluminescence (fi  lled sym-
bols, +/+; open symbols, −/−). Triplicate wells of mock-primed or 
mTNF-α–, mGM-CSF–primed BMNs (3.75 × 105 BMN/well for S. aureus 
and zymosan stimulations, 1.25 × 106/well for latex beads stimulations) 
were stimulated in a luminometer and ROS production (measured in rela-
tive light units per second, rlu/sec) was followed over time (A). Each hori-
zontal panel of graphs is shown on the same scale. Data are means ± SD 
from a single experiment representative of two to fi  ve independent ex-
periments. Particles were either unopsonized or opsonized with IgG or 
mouse serum. Particle/BMN ratios are as follows: zymosan, 5:1; S. aureus, 
20:1; IgG latex beads, 50:1. (B) Total integrated responses of primed BMNs 
to different stimuli over 2 h are shown as a percentage of wild-type. 
Black, +/+; white, −/−. Data are means ± SE (n = 6–10) from two to 
fi  ve independent experiments using three to six mice per preparation.
Figure 5.  NADPH oxidase responses of p40phox−/− neutrophils 
  assessed by measuring oxygen consumption and phagosomal NBT 
deposition. Oxygen consumption of BMNs from p40phox+/+ and 
p40phox−/− animals, in response to various stimuli, was measured in a 
Clark-type oxygen electrode. Primed BMNs (5 × 106/ml) were prewarmed 
in the oxygen electrode chamber, stimuli were added, and oxygen con-
sumption was followed over time. Line graphs (A) are typical examples 
of each stimulus: 1 μM PMA, IgG-Zym (20 particles per neutrophil), and 
heat-killed S. aureus (20 bacteria per neutrophil). S. aureus was heat killed 
before addition, as oxygen consumption by live bacteria dominated the 
neutrophil respiratory burst (unpublished data). BMNs were primed before 
IgG-Zym and S. aureus stimulation. (B) Quantifi  cation of rates of oxygen 
consumption as a percentage of wild-type, after deduction of prestimulus 
rate of oxygen consumption. Data are means ± SE (n = 3–5) from three 
to fi  ve independent experiments using three to six mice per preparation. 
(C) Primed BMNs were adhered to glass in the presence of NBT, IgG-Zym 
was added, and superoxide production (evident by the deposition of dark 
purple formazan precipitate) was imaged microscopically. Arrowheads 
indicate examples of NBT+ phagosomes. Images show typical results 
 30 min after IgG-Zym addition (n = 5 experiments using three to six 
mice per preparation).1932  P40PHOX IS REQUIRED FOR BACTERIAL KILLING | Ellson et al.
Thus, p40phox plays an essential role in the pathways between 
integrin engagement and oxidase activation in these contexts 
of neutrophil activation.
p40phox−/− neutrophils exhibit a severe defi  ciency 
in bacterial killing in vitro
Killing of S. aureus by neutrophils in vitro is highly depen-
dent on NADPH oxidase activity, consistent with the high 
frequency with which S. aureus infections present in cases of 
CGD (9, 10). In contrast, killing of Escherichia coli is relatively 
independent of neutrophil NADPH oxidase activity (61). 
In line with these conclusions, we found that the NADPH 
oxidase inhibitor diphenyleneiodonium chloride (DPI) had a 
much greater eff  ect on the killing of S. aureus by BMNs than 
the killing of E. coli (Fig. 7, A and B). BMNs from p40phox−/− 
mice had a clear defect in the killing of S. aureus ( 75% rela-
tive to wild-type) but an insignifi  cant defect in the killing 
of E. coli (Fig. 7, A and B). This defect was mirrored in the 
killing of S. aureus by whole blood (Fig. S3, available at 
http://www.jem.org/cgi/content/full/jem.20052069/DC1). 
Using a range of DPI concentrations to construct a relation-
ship between BMN NADPH oxidase activity and S. aureus 
killing (61), the NADPH oxidase defi  ciency of p40phox−/− 
neutrophils correlates well with their defi  ciency in S. aureus 
killing (Fig. 7 C), suggesting that the two are causally linked.
p40phox−/− mice are defi  cient in clearing an S. aureus 
infection in vivo
We sought to establish whether the substantial defect in the 
in vitro killing of S. aureus by p40phox−/− neutrophils trans-
lated into a defect in the killing of this organism in the whole 
animal. We injected live S. aureus into the peritoneum of 
p40phox−/− and p40phox+/+ mice and measured the number of 
surviving bacteria over the subsequent 24 h. We reproduc-
ibly recovered signifi   cantly more live S. aureus from the 
p40phox−/− mice than their wild-type controls (Fig. 7 D).
DISCUSSION
We observed very substantial defects in NADPH oxidase ac-
tivity in neutrophils isolated from p40phox−/− mice, defi  ning 
an essential role for p40phox in the physiological regulation of 
this important enzyme complex. The degree of defect in 
NADPH oxidase activity varied greatly depending on the na-
ture of the stimulus. Large defects were observed in intracel-
lular ROS production in response to S. aureus or IgG latex 
beads, and smaller defects were observed in response to the 
uptake of zymosan. Extracellular ROS generation was absent 
in response to TNF-α/fi   brinogen and greatly reduced in 
  response to FMLP or PMA. ROS stimulation by TNF-α/ 
fi   brinogen is thought to occur via costimulation of β2 
  integrins and TNF-α receptors (59, 62). FMLP is thought to 
activate the oxidase via formyl-peptide receptors (63) and 
IgG to act via Fcγ receptors (64). S. aureus and zymosan are 
complex stimuli that are engulfed and activate the oxidase 
through a combination of inaccurately defi  ned receptor types, 
but these are likely to include β2 integrin receptors (64) and 
β glucan receptors (65). Furthermore, these receptor types 
are likely to be extended in vivo through opsonization with 
complement or antibodies. Thus, it is clear that loss of p40phox 
has a diff  erential impact in the signaling pathways from diff  er-
ent receptor subtypes. The extent of p40phox involvement in 
the various physiological mechanisms of NADPH oxidase 
activation in neutrophils and other cell types will only be re-
solved with much further work, but our in vitro and in vivo 
Figure 6.  p40phox−/− neutrophils have severe defi  ciencies in adhe-
sion-dependent ROS production. BMNs from p40phox+/+ and p40phox−/− 
animals were analyzed for adhesion-dependent ROS production using 
HRP-dependent, luminol-dependent chemiluminescence on fi  brinogen-
coated plates (fi  lled symbols, +/+; open symbols, −/−). Duplicate wells 
of BMNs (2.5 × 105/well) were stimulated in a luminometer and ROS 
production (measured in relative light units per second, rlu/sec) was fol-
lowed over time. 20 ng/ml mTNF-α (A) and 18 μg/ml anti-CD18 (anti-β2 
integrin) (B). Dotted lines are wild-type controls stimulated with buffer alone 
in A and IgG2a isotype control in B. Data are means ± range from a sin-
gle experiment representative of three independent experiments. (C) Total 
integrated responses over 1 h as a percentage of wild-type. Data are 
means ± SE (n = 6) from three independent experiments. (D) Spreading 
responses on fi  brinogen surfaces of TNF-α–stimulated neutrophils. Phase 
dark cells are considered spread. (E) Cell surface expression of CD18 in 
TNF-α–stimulated neutrophils. Solid lines are anti-CD18, and dotted lines 
are isotype controls. Black, +/+; gray, −/−. Data are from a single 
  experiment representative of two independent experiments.JEM VOL. 203, August 7, 2006  1933
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models of oxidant-dependent bacterial killing already indi-
cate that it is a critical component of our innate defense 
mechanism (Fig. 7). Importantly, the extent of the S. aureus 
killing defect is as severe as that observed with neutrophils 
from p47phox−/− CGD model mice (3, 66).
A key question is clearly the molecular mechanism by 
which p40phox acts in the signaling pathways to NADPH oxi-
dase activation. We observed that p67phox levels are reduced 
by  55% in p40phox−/− neutrophils. p67phox and p40phox are 
established to exist in a complex in neutrophils, although the 
stoichiometry and relative inclusion of p47phox in the resting 
state are still in debate. In p67phox-defi  cient CGD patients, 
p40phox expression is reduced (34, 67, 68), suggesting that 
p40phox and p67phox mutually regulate each other’s steady-state 
expression, and this is supported by the reduced p67phox levels 
in p40phox−/− neutrophils. Whether this regulation occurs at 
the level of protein stability, mRNA stability, or transcrip-
tional/translational control is unknown. It is established that 
p67phox is an absolute requirement for reconstituted NADPH 
oxidase activity in vitro and, through characterized cases of 
CGD, also in vivo. Thus, the drop in p67phox levels in the 
p40phox−/− neutrophils is a confounding issue in trying to as-
cribe molecular consequences to the loss of p40phox. There is 
the possibility that this reduction in p67phox has an impact di-
rectly on the oxidase, and there is also the possibility that this 
has an impact indirectly, via altering the dependence on other 
subunits. Unfortunately, the absence of a p67phox−/− mouse 
model prevents a simple assessment of this impact in p67phox+/− 
mice; however, we note that human carriers of p67phox-
  defi  cient CGD do not present with a CGD phenotype (69). 
Further, the very large reductions in oxidase responses to 
TNF-α/fi  brinogen and S. aureus in p40phox−/− neutrophils 
suggest that p40phox has a substantial role in these responses 
under normal circumstances.
Earlier work has suggested that PtdIns3P binding to the 
PX domain of p40phox may play a role linking PI3K signaling 
pathways to NADPH oxidase activation (22, 37, 46, 47). 
Furthermore, the discovery that PtdIns3P synthesis can occur 
on phagosomal membranes provided a context for this po-
tential mechanism (70, 71). Evidence that this pathway does 
indeed operate in FcγRII receptor stimulation of the NADPH 
oxidase in the COS phox system is provided in an accompa-
nying article by Suh et al. (on p. 1915 of this issue; reference 
72). In this elegantly engineered cell model, an intact Ptd-
Ins3P-binding PX domain of p40phox is shown to be required 
for FcγRII receptor–initiated phagosomal ROS production. 
Our data describing the very large reduction in IgG latex 
bead–stimulated ROS production in p40phox−/− neutrophils 
provides strong in vivo corroboration of this model. How-
ever, further work must clearly be done measuring elements 
of the known pathways to NADPH oxidase activation (e.g., 
p47phox/p67phox/p40phox phosphorylation, p47phox/p67phox/rac-2 
translocation to cytochrome b558) before the molecular conse-
quences of the absence of p40phox can be properly ascribed, 
and it is likely that these will need to be done in the context 
of replenishment of p67phox and/or knock-in mutations of 
p40phox before clear answers emerge. However, the develop-
ment of the p40phox−/− mouse does appear to off  er a potential 
route to answering these questions.
The absence of examples of CGD patients characterized 
by mutations in p40phox together with enigmatic data arising 
from attempts to reconstitute the NADPH oxidase in cellular 
and a-cellular systems lead to the general view that p40phox 
does not have a critical role in NADPH oxidase activation. 
A counter argument arising from data describing widespread 
tissue expression of p40phox suggested that this protein may 
have a wider role outside of phagocytes (73), precluding the 
presentation of p40phox dysfunction as CGD. This argument is 
Figure 7.  p40phox−/− neutrophils are severely defi  cient in killing of 
S. aureus in vitro and in vivo. (A and B) Primed BMNs from p40phox+/+ 
and p40phox−/− animals were incubated for 15 min with serum-opsonized 
S. aureus (approximate ratio of 1 bacterium to 4 neutrophils) (A) or 5 min 
with serum-opsonized E. coli (approximate ratio of 1 bacterium to 1 neu-
trophil) (B) with rapid mixing. Samples were added to ice-cold LB-saponin 
and sonicated to liberate ingested bacteria. Surviving bacteria were enu-
merated by plating and subsequent counting of colonies. “No neutrophil” 
controls and controls with 3 μM DPI were also run. Data are means ± SD 
(n = 3) and representative of two to fi  ve experiments using three to six 
mice per preparation. (C) A dose curve of DPI (0.003–10 μM) was applied 
to wild-type mouse neutrophils in parallel luminometer-based ROS pro-
duction assays in response to S. aureus and S. aureus killing assays. Resul-
tant NADPH oxidase activity and S. aureus survival values were plotted 
against each other (fi  lled symbols) and a trendline was fi  tted, representing 
the dependence of killing on NADPH oxidase activity in wild-type neutro-
phils. The data point for p40phox−/− neutrophils in response to S. aureus 
(bacterial killing vs. NADPH oxidase activity) was plotted on the same 
graph (open symbol). Data are means ± SE (n = 6) from two to three 
independent experiments using three to six mice per preparation. (D) Mice 
were injected intraperitoneally with 5 × 107 live S. aureus. After 4 or 24 h, 
mice were killed and peritoneums were fl  ushed with ice-cold buffer. Ali-
quots were added to ice-cold LB-saponin, sonicated to liberate ingested 
bacteria, diluted, and plated, and surviving bacteria were enumerated. 
Total numbers of surviving bacteria per animal were calculated for each 
time point. Black, p40phox+/+; white, p40phox−/−. Data are means ± SE 
(n = 3 mice per time point) from a single experiment representative of 
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not supported by our initial characterization of p40phox ex-
pression in the p40phox−/− mice, which did not provide evi-
dence for high expression of p40phox outside the haemopoetic 
system, nor by the fact that p40phox−/− mice appear healthy 
when raised under pathogen-free conditions. It seems plausi-
ble that either a loss of p40phox presents a mild phenotype in 
humans or, indeed, that several uncharacterized cases of 
CGD-like immunodefi  ciencies may arise from as yet unde-
scribed mutations in the p40phox gene.
MATERIALS AND METHODS
Murine GM-CSF (mGM-CSF), FMLP, luminol, DPI, and HRP were from 
Sigma-Aldrich. Murine TNF-α (mTNF-α) was from R&D Systems. All 
buff  er components were from Sigma-Aldrich and were endotoxin free or 
low endotoxin, as available. The following antibodies were used: anti–phospho-
Ser473 PKB (Ab4802; Abcam), anti-PKB (9272; Cell Signaling), anti–
  phospho-T180/Y182 p38 (9211S; Cell Signaling), anti-p38 (9212; Cell 
Signaling), anti–phospho-T202/Y204 p42/44 (9106S; Cell Signaling), and 
anti-p42/22 (606-259-1550; TransLabs).
Generation of p40phox−/− mice. Several clones encoding the p40phox geno-
mic sequence were isolated from the RPCI mouse PAC library 21 (Pieter de 
Jong, UK HGMP Resource Centre) by Southern screens using an NT-cDNA 
probe. An 11.9-kb SpeI–SpeI fragment encompassing exons 1–4 was isolated 
from clone RP21-641C7 and inserted into the low copy number plasmid 
pSC-3Z to form the basis of a p40phox gene-targeting vector (Fig. S1 A).
A smaller fragment containing exon 3 was subcloned into pBS, and site-
directed mutagenesis was conducted to alter codon 73 to a translational stop 
and to introduce silent mutations creating additional XhoI and ApaI sites 
(Fig. S1 B), which were used to track the presence of the mutated sequence. 
This modifi  ed segment was sequenced and reintroduced into the targeting 
vector. This strategy was adopted because the translational stop or p40phox−/− 
mouse described here was one of several knock-in mutations planned 
for exon 3.
A loxP-fl   anked cassette containing a tACE-Cre expression module 
and a NeoR expression module (pACN; A. Plagge, Babraham Institute, 
Cambridge, UK) (74) was inserted into the SnaBI site in the intron between 
exons 3 and 4 (Fig. S1 A). The tACE promoter is expected to operate in the 
testis and drive Cre/Lox-mediated deletion of this cassette on the breeding 
of targeted chimeras. Deletion is predicted to leave 59 bp of foreign DNA 
remaining in the intron.
The fi  nal targeting vector was digested with DraI and SalI (in the 3′ 
polylinker) to remove excess pSC-3Z vector sequence and used to transfect 
E14 129s/v embryonic stem cells by the Gene-Targeting Facility at the 
Babraham Institute. 500 clones were initially screened for homologous 
  recombination using a 3′ Southern screen (probe 3′ to targeted sequence, 
EcoRI digest, 4.6–8.3 kb transition), and positive clones were rescreened by 
a 5′ Southern screen (probe 5′ to targeted sequence, SpeI digest, 11.9–10.0 kb 
transition) and for single insertion of the NeoR cassette (Neo probe, 
EcoRI/8.3 kb, and SpeI/5.7 kb; Fig. S1, A and C). Three clones were taken 
forward for blastocyst injection, and male chimeras from these mice were 
bred with female C57BL/6 animals to generate p40phox+/− heterozygotes on 
a mixed 129s/v/C57BL/6 background. Deletion of the NeoR cassette was 
confi   rmed by appropriate Southern and PCR analyses, and separate 
p40phox−/− colonies were created from each of the original targeted embry-
onic stem cell lines and housed under specifi  c pathogen-free conditions in 
the SABU facility at the Babraham Institute. Genotyping of the mice was 
routinely performed by PCR amplifi  cation of an approximately 850-bp re-
gion fl  anking exon 3 (to include the inserted translational stop and additional 
XhoI and ApaI sites) and subsequent diagnosis by susceptibility of the prod-
uct to cleavage by XhoI or ApaI (to yield  525- and 325-bp fragments; 
Fig. S1 D). All mice used were 2–8-mo old and showed no age-dependent 
variation. This work was covered by UK Home Offi   ce Project License 
PPL 80/1875.
Preparation of BMNs. BMNs were prepared as described previously with 
minor modifi  cations (75). Bone marrow, from at least three mice per prepa-
ration, was dispersed in HBSS (without Ca2+ and Mg2+), 0.25% fatty acid–
free BSA, 15 mM Hepes, pH7.4, at room temperature and purifi  ed over 
discontinuous Percoll (GE Healthcare) gradients. After washes, mature neu-
trophils were resuspended in Dulbecco’s PBS with Ca2+ and Mg2+, 1 g/liter 
glucose, 4 mM sodium bicarbonate (DPBS+). Purity was typically 70–80% 
as assessed by cytospin and REASTAIN Quick-Diff    (Reagena)  staining 
(non-neutrophils were  50% immature white cells, 25% monocytes, and 
25% lymphocytes). All assays were performed in DPBS+. BMNs were 
primed at 37°C with 500 U/ml mTNF-α, 100 ng/ml mGM-CSF, and 10% 
mouse serum for 60 min. In some experiments, as indicated, BMNs were 
primed individually with 500 U/ml mTNF-α for 30 min, 100 ng/ml 
mGM-CSF for 60 min, or 500 U/ml mTNF-α and 100 ng/ml mGM-CSF 
for 60 min.
Neutrophil and multiple tissue Western blots. 5 × 106 BMNs were 
sonicated into 1× SDS loading buff  er, and 5 × 105 cell equivalents were 
subjected to SDS-PAGE, transferred, and blotted for p40phox (05-539 mono-
clonal; Upstate Biotechnology; sc-18252 and sc-18253 polyclonals; Santa 
Cruz Biotechnology, Inc.), p47phox (07-500 polyclonal; Upstate Biotechnol-
ogy), and p67phox (07-502 polyclonal; Upstate Biotechnology). Signal was 
detected (Image Reader LAS-1000; Fugifi  lm) and quantifi  ed using Aida Image 
Analyser 2.2. For tissue Westerns, tissues were collected and immediately 
machinated into ice-cold 20 mM Hepes, pH7.1, at 4°C, 0.1% SDS, 0.4% 
cholate, 0.1% NP-40, 0.1M NaCl, 0.2 mM PMSF, and 10 μg/ml each of 
pepstatin A, leupeptin, antipain, and aprotinin and clarifi  ed by centrifugation 
(14,000 g for 30 min at 4°C). Protein concentrations were determined (BCA; 
Pierce Chemical Co.), and 30 μg of each protein was subjected to SDS-
PAGE, transferred, and immunoblotted for p40phox.
PKB, p38 MAPK, and p42/44 Erk activation assays. 5 × 106 unprimed 
BMNs from p40phox−/− and p40phox+/+ mice were prewarmed for 3 min at 
37°C at 5 × 107/ml in DPBS+ in duplicate. After 1 min of stimulation with 
prewarmed FMLP (10 μM fi  nal) or salts, reactions were stopped by the ad-
dition of excess ice-cold PBS, followed by immediate centrifugation (12,000 g 
for 10 s). Cell pellets were lysed in 20 mM Tris, pH 7.5 at 4°C, 150 mM 
NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium 
  pyrophosphate, 1 mM β-glycerophosphate, 1 mM sodium orthovanadate, 
0.2 mM PMSF, and 10 μg/ml each of pepstatin A, leupeptin, antipain, and 
aprotinin and incubated on ice for 10 min. Cytoskeletal debris was removed 
by centrifugation (12,000 g for 20 min at 4°C). Lysates were split between 
two SDS-PAGE gels and blotted for phospho- and total protein, respec-
tively. Blots were imaged and quantifi  ed as described above.
Preparation of mouse serum. Mouse blood was collected and left to clot 
at room temperature for 45 min in a glass container before transferal to a 
15-ml tube followed by centrifugation (1,500 g for 10 min at room tempera-
ture). Serum was removed to a fresh tube, recentrifuged, recovered, placed 
on ice, aliquoted, and stored at −80°C.
Chemiluminescent detection of ROS. ROS production was measured 
by luminol-dependent chemiluminescence in polystyrene 96-well plates 
(no. 23300; Berthold Technologies Ltd.) as described previously (75) in 
DPBS+, except fi  nal concentrations of luminol and HRP were 150 μM and 
18.75 U/ml, respectively. Prewarmed stimuli were added manually and 
measurement started immediately. Assays using soluble stimuli (PMA, 
FMLP, and mTNF-α) were conducted in the presence of exogenous added 
HRP; the signal was >95% HRP dependent, indicating predominantly 
  extracellular ROS production (unpublished data). Assays using particulate 
stimuli (zymosan, IgG latex beads, and live S. aureus) were conducted with-
out HRP and thus represent intracellular ROS production. The addition of 
HRP revealed little extracellular ROS production (unpublished data). Final 
particle/BMN ratios were as follows: zymosan, 5:1; S. aureus, 20:1; and IgG 
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with varying concentrations of DPI or vehicle (DMSO) alone before stimu-
lation. Data output is in relative light units per second (rlu/s).
Adhesion-dependent responses. Surfaces (96-well plates or 12-well tis-
sue culture plates) were coated overnight at 4°C with sheep fi  brinogen 
(F9754; Sigma-Aldrich) at 150 μg/ml in PBS (100% FCS was used as a non-
specifi  c control). Before use, surfaces were washed three times with PBS. 
For adhesion-dependent ROS assays, neutrophils at 5 × 106/ml were incu-
bated at 37°C for 1 h before the addition of prewarmed 2× HRP/luminol 
followed by mTNF-α (fi  nal concentration of 20 ng/ml), anti-CD18 (anti–
β2 integrin, M18/2; Chemicon), or IgG2a isotype control antibodies (fi  nal 
concentration of 18 μg/ml). Cells were immediately aliquoted into the plate 
(100  μl/well) and counted. For spreading experiments, preincubated 
  neutrophils were incubated at 37°C in coated 12-well tissue culture plates 
(6.25 × 105/well) in the presence of 20 ng/ml mTNF-α. After 40 min, 
wells were aspirated and cells were fi   xed in 3.8% formaldehyde. Non-
  adhered cells were washed away and remaining cells were visualized by light 
microscopy. In both ROS and spreading assays, FCS-coated wells produced 
minimal responses (unpublished data). For analysis of β2 integrin expression, 
neutrophils were stimulated with mTNF-α for 30 min at 37°C, placed on 
ice, and processed for FACS analysis using the anti-CD18 antibody, its iso-
type control, and an FITC anti–rat secondary.
Preparation of particulate stimuli. IgG-opsonized zymosan particles 
(IgG-Zym) were prepared as per the manufacturer’s instructions (unlabeled 
zymosan A, Z-2849, and rabbit anti-zymosan A, Z-2850; Invitrogen). 
  Zymosan and S. aureus were serum opsonized or mock opsonized by incuba-
tion in DPBS+ with or without 50% mouse serum at 37°C with end-over-
end mixing for 1 h (zymosan) or 15 min (S. aureus) followed by washing. 
Carboxylate-modifi  ed latex beads (0.9-μm diameter; Sigma-Aldrich) were 
cross-linked to sulfhydryl-modifi   ed BSA and coated with an anti-BSA 
monoclonal antibody (Sigma-Aldrich) or not, as described previously 
(IgG latex beads) (76). Where appropriate, S. aureus was washed and resus-
pended in DPBS+ (4 × 108/ml), heat killed at 60°C for 30 min, and opso-
nized in mouse serum as described above.
S. aureus phagocytosis assay. 106 primed BMNs were allowed to adhere 
to glass coverslips for 20 min at 37°C. They were then aspirated, 107 FITC-
  labeled, serum-opsonized S. aureus was added, and they were returned to 
37°C (FITC labeling of bacteria as described previously [77] and opsoniza-
tion as detailed above). After 40 min, coverslips were washed, fi  xed in 4% 
paraformaldehyde, and mounted. Postfi  xation probing with a rabbit anti–
S. aureus antibody (S-2860; Invitrogen) and goat anti–rabbit Alexa Fluor 568 
secondary antibody (Invitrogen) revealed that >95% of bacteria present 
were internalized. Phagocytosed bacteria were visualized by fl  uorescence 
microscopy and enumerated.
Oxygen consumption. Oxygen consumption was measured in a Clark-
type oxygen electrode (Rank Brothers Ltd.) at 37°C with rapid stirring. 
Primed BMNs were added to the rapidly stirred chamber at 5 × 106/ml and 
equilibrated for 5 min before the addition of prewarmed stimuli. Final con-
centrations were 1 μM PMA; IgG-Zym, 20:1; and heat-killed S. aureus, 
20:1 (particles/BMNs).
NBT microscopy. Primed BMNs were adhered to a coverslip in 0.5 mg/ml 
NBT at 37°C. IgG-Zym particles were added, and dark purple formazan 
  deposition was followed during phagocytosis by bright fi  eld microscopy.
In vitro bacterial killing assays. Bacteria (S. aureus Wood 46 and E. coli 
E2348169) were subcultured at 37°C to logarithmic growth from an over-
night culture. 4 × 107 bacteria were washed in DPBS+ and opsonized as 
  described above. Opsonized bacteria (1.5 × 106 S. aureus and 6 × 106 E. coli) 
were added to 6.2 × 106 primed BMNs (2.5 × 107/ml) at 37°C with rapid 
orbital mixing. After the indicated times, 50-μl aliquots were removed to 
950-μl ice-cold Luria broth (LB) containing 0.05% saponin. Samples were 
sonicated (output 1.5 for 10 s; Sonicator 3000; Misonix) to liberate intracel-
lular bacteria and returned to ice. Suspensions were serially diluted and 
plated on LB-agar to enumerate surviving bacteria. A parallel bacterial incu-
bation was also run in the absence of neutrophils. In some experiments, neu-
trophils were incubated for 5 min with DPI at varying concentrations or 
vehicle (DMSO) alone before the addition of bacteria (oxidant-dependent 
killing control).
For S. aureus killing assays in whole blood, 2.5 × 106 bacteria in 1 ml 
DPBS+ were added to 1 ml of fresh whole blood (mixed from at least three 
animals) and incubated for 20 min at 37°C with end-over-end mixing. 
0.8 ml of blood/bacteria mix was added to tubes containing lysostaphin 
(a fi  nal concentration of 2.5 U/ml to kill extracellular bacteria) in duplicate 
and returned to mixing. Samples were taken after 1 h, added to ice-cold 
PBS, and pelleted by centrifugation, and the pellets were resuspended in 
0.5 ml nutrient broth, 0.05% saponin. Samples were then processed and 
quantifi  ed as described above.
In vivo S. aureus survival assays. S. aureus (LS-1) was subcultured at 37°C 
to logarithmic growth from an overnight culture. Bacteria were washed and 
resuspended in injection-grade PBS at 2.5 × 108/ml. Three animals of each 
genotype per time point were injected intraperitoneally with 0.2 ml of bac-
terial suspension (5 × 107 bacteria). After 4 or 24 h, mice were killed and the 
peritoneal cavity was thoroughly fl  ushed with 10 ml ice-cold PBS, 5 mM 
EDTA, and 5 U/ml heparin. Aliquots were diluted, sonicated, and plated, 
and bacteria were enumerated as for the in vitro killing assays.
Online supplemental material. Fig. S1 illustrates the targeting stra  t-
egy used to generate p40phox−/− mice and the subsequent screening strategies 
used. Fig. S2 denotes normal organ weights of p40phox−/− animals. 
Fig. S3 describes the S. aureus killing defi  ciency of whole blood from 
p40phox−/− animals.
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